.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Argus Health
Medtronic
Daiichi Sankyo
Baxter
Cerilliant
Chinese Patent Office
Express Scripts
Fish and Richardson
Citi

Generated: June 23, 2017

DrugPatentWatch Database Preview

KENACORT Drug Profile

« Back to Dashboard

Which patents cover Kenacort, and when can generic versions of Kenacort launch?

Kenacort is a drug marketed by Delcor Asset Corp and is included in two NDAs.

The generic ingredient in KENACORT is triamcinolone. There are fifty drug master file entries for this compound. Additional details are available on the triamcinolone profile page.

Summary for Tradename: KENACORT

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list40
Clinical Trials: see list2
Patent Applications: see list6,412
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KENACORT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp
KENACORT
triamcinolone diacetate
SYRUP;ORAL012515-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-010Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Fuji
Colorcon
Queensland Health
Boehringer Ingelheim
Fish and Richardson
Cipla
Chinese Patent Office
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot